CASPR Biotech
CASPR Biotech was a San Francisco–based CRISPR-based molecular diagnostics startup founded in 2019, developing nucleic acid detection platforms for pathogen identification, whose team was integrated into Amazon's Lab126 devices division by 2020.
- Company typePublic
- Founded1994
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CASPR Biotech does
CASPR Biotech was a biotechnology company founded in 2019 and headquartered in San Francisco, California, that developed CRISPR-based molecular diagnostic platforms for nucleic acid detection and pathogen identification. The company's core technology leveraged CRISPR-Cas enzyme systems — a class of programmable DNA/RNA-targeting enzymes — to build assays capable of recognizing specific genetic signatures, with potential applications in infectious disease diagnostics. The technical team, led by co-founders Federico Pereyra-Bonnet (Chief Research Officer) and Franco Goytia (CEO), Chief Strategy Officer Carla Gimenez, and Assay Development Lead Lucia Curti, was structured around R&D execution rather than commercial scale-up, consistent with an early-stage technology developer.
The company was capitalized with approximately $2.55 million across five funding events between November 2018 and May 2020, with SOSV/IndieBio disclosed as a participating investor in two rounds. By 2020, CASPR Biotech's operational identity had been redirected to Amazon's Lab126 devices-and-services hardware division, as evidenced by the company website URL now resolving to amazon.jobs Lab126; the firmographic short_description explicitly states the company "Joined Amazon in 2020." No customer base, pricing model, revenue mechanics, distribution channels, products, patents, or commercial partnerships are disclosed in the input data. As of the available evidence, CASPR Biotech does not exist as an independent commercial entity, and its diagnostics capability now sits inside Amazon's broader devices and services portfolio.
CASPR Biotech firmographics
Firmographics- Name
- CASPR Biotech
- Legal name
- Amazon.com, Inc.
- Website
- https://amazon.jobs
- Company type
- Public
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CASPR Biotech was a San Francisco–based CRISPR-based molecular diagnostics startup founded in 2019, developing nucleic acid detection platforms for pathogen identification, whose team was integrated into Amazon's Lab126 devices division by 2020.
- Ownership category
- akta.pro rank
CASPR Biotech industry classification
Industry- Product category
- Biotechnology Research
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
Keywords
Where CASPR Biotech is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
CASPR Biotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
CASPR Biotech product offering
Product offeringCore offering
CASPR Biotech is a San Francisco-based biotechnology company founded in 2019 that focused on assay development and biotechnology research. The company was acquired by Amazon in 2020, with its operations absorbed into Amazon's Lab126 hardware research and development division, suggesting its biotech capabilities were integrated into Amazon's devices and services portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- Amazon Web Services (AWS): Cloud computing platform offering infrastructure, storage, and computing services
- Alexa
- Amazon Prime Video
- Amazon Kindle
- Ring
- Fire TV
- Amazon Leo
- Amazon Dedicated Cloud
- Amazon University Talent Acquisition (AUTA)
- Amazon Leadership Principles
Companies that use CASPR Biotech
Customer profileIdeal customer profiles1 record
CASPR Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CASPR Biotech partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights3 records
CASPR Biotech competitors and assessment
Company assessmentDirect peers
- Mammoth Biosciences: Mammoth Biosciences is a CRISPR-based diagnostic and therapeutic platform company. It is a direct peer to CASPR Biotech as both are CRISPR-focused startups that emerged from the same IndieBio/SOSV-adjacent ecosystem, pursuing diagnostic applications of CRISPR technology.
- Sherlock Biosciences: Sherlock Biosciences develops CRISPR-based diagnostics for infectious disease and oncology. It directly competes with CASPR Biotech in the CRISPR diagnostics category and has secured significant venture funding and partnerships to commercialize its platform.
- CRISPR Therapeutics: CRISPR Therapeutics is a leading gene-editing biotechnology company developing CRISPR/Cas9-based therapeutics. While more therapeutics-focused, it shares the same foundational CRISPR technology stack as CASPR Biotech and competes for talent and partnerships in the broader CRISPR ecosystem.
- Editas Medicine: Editas Medicine is a clinical-stage genome editing company leveraging CRISPR-based technology. As one of the original CRISPR biotechs, it serves as a reference peer for CASPR Biotech in terms of technology platform development and commercialization pathways.
- Caribou Biosciences: Caribou Biosciences develops CRISPR-based genome editing technologies for therapeutic applications. It is comparable to CASPR Biotech as a CRISPR platform company with technology originating from leading academic labs and pursuing both research tools and clinical applications.
- Beam Therapeutics: Beam Therapeutics is a biotechnology company developing precision genetic medicines using base editing technology. It is comparable to CASPR Biotech as a next-generation gene editing platform pursuing programmable biology applications.
Broad incumbents
- Synthego: Synthego is a genome engineering company providing CRISPR-based tools and services to researchers. It serves as a broader incumbent in the CRISPR ecosystem that CASPR Biotech would have engaged with as both a potential supplier and competitor for diagnostic applications.
- Twist Bioscience: Twist Bioscience is a synthetic biology company providing DNA synthesis and genomics products. As a broader synthetic biology platform, it is comparable to CASPR Biotech's likely synthetic biology and assay development focus areas.
- Ginkgo Bioworks: Ginkgo Bioworks is a major synthetic biology platform company. It is comparable to CASPR Biotech as a programmable biology and synthetic biology platform, though at vastly greater scale and broader scope across industrial and diagnostic applications.
Emerging players
- Inscripta: Inscripta (now known as Muse Biotechnology) develops CRISPR-enabled tools for gene editing and synthetic biology. It overlaps with CASPR Biotech in programmable biology and gene editing tool development for research and industrial applications.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
CASPR Biotech social profiles
Digital presenceCASPR Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
CASPR Biotech leadership team
Management profileNumber of profiles
CASPR Biotech subsidiaries and ownership
Company hierarchySubsidiaries18 records
CASPR Biotech funding detail
Funding detailFunding overview
Funding rounds5 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CASPR Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CASPR Biotech
What does CASPR Biotech do?
CASPR Biotech is a San Francisco-based biotechnology company founded in 2019 that focused on assay development and biotechnology research. The company was acquired by Amazon in 2020, with its operations absorbed into Amazon's Lab126 hardware research and development division, suggesting its biotech capabilities were integrated into Amazon's devices and services portfolio.
Is CASPR Biotech a public or private company?
CASPR Biotech is a public company. It is classified as corporate owned and is currently operating.
When was CASPR Biotech founded?
CASPR Biotech was founded in 1994. It employs 11 to 50 people.
Where is CASPR Biotech based?
CASPR Biotech is headquartered in San Francisco, United States, in the North America region.
Who are CASPR Biotech's main competitors?
Direct peers on record are Mammoth Biosciences, Sherlock Biosciences, CRISPR Therapeutics, Editas Medicine, Caribou Biosciences and Beam Therapeutics. Broad incumbents are Synthego, Twist Bioscience and Ginkgo Bioworks. Inscripta is listed as an emerging player.
Does CASPR Biotech have an API?
No public API is recorded for CASPR Biotech.
What industry is CASPR Biotech in?
CASPR Biotech's product category is Biotechnology Research. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development). Its NAICS code is 325414 and its SIC code is 2834.